Home

JAMES V CARUSO

CIK 1202770 · President & CEO · last filed 2026-07-08

JAMES V CARUSO is a President & CEO who has filed 36 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for CLRB, was dated Jul 8, 2026. Across all open-market trades the lifetime net is −$2.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $50.8K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$50.8K

Companies

5

Total Filings

36

Lifetime Open-Market Net

-$2.74M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CLRB President & CEO 20,318 $2.50 $50.8K $74.9K 8 2026-07-08
Cellectar Biosciences, Inc. (CLRBZ) Delisted President and CEO 86,401 $0.12 $10.3K $45.1K 10 2021-03-05
Cellectar Biosciences, Inc. (CLRB.W) Delisted President and CEO 6,000 — — $8.3K 4 2016-05-23
Cellectar Biosciences, Inc. (CLRB.Z) Delisted President and CEO 47,548 — — $99.5K 1 2016-04-21
ALLOS THERAPEUTICS INC (ALTH) Delisted Chief Commercial Officer 103,659 — — -$2.97M 13 2010-03-03

Recent Filings

36 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-08 CLRB Grant (A) — $0 EDGAR
2026-05-11 CLRB Buy (P) +8,680 $25.0K EDGAR
2025-07-03 CLRB Buy (P) +10,000 $49.9K EDGAR
2025-02-18 CLRB Grant (A) — $0 EDGAR
2024-06-18 CLRB Grant (A) — $0 EDGAR
2023-12-12 CLRB Grant (A) +40,596 $0 EDGAR
2023-01-18 CLRB Grant (A) — $0 EDGAR
2022-01-27 CLRB Grant (A) — $0 EDGAR
2021-03-05 Cellectar Biosciences, Inc. (CLRBZ) Delisted Mixed +5,100 $8.7K EDGAR
2020-12-28 Cellectar Biosciences, Inc. (CLRBZ) Delisted Buy (P) +37,037 $50.0K EDGAR
Showing 1–10 of 36
Page 1 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.